Latest Articles

Technology Networks invited chief editor at Nature Biotechnology, Barbara Cheifet, to an Ask Me Anything session to answer questions about the biggest challenges in scientific publishing and how to get work published in high-ranking journals.

Using data provided by Intercontinental Exchange, My Green Lab has produced a report providing key insights into the current state of the sector’s carbon emissions. James Connelly highlights some of the key findings and their significance.

Neurodegenerative diseases are characterized by synapse dysfunction and the aggregation of proteins in the brain, which ultimately lead to neuronal loss. This article will review the studies and methods powering our growing understanding of the mechanisms behind neurodegenerative disease.

This article explores how biopharmaceutical organizations seeking to remain competitive must adopt innovations, like cell-free long DNA synthesis, to unleash the potential of synthetic biology and accelerate therapeutic development across all facets of genetic medicine.

Dr. Darrell Green's best friend, Ben, developed bone cancer and passed away just before his 14th birthday. This profile article explores how this experience stayed with Green, and has propelled his work towards a new treatment for bone cancer.

A diverse array of biological medicines are now used to prevent and treat a wide range of illnesses. This article will discuss the development of cell lines in biopharma and will touch on key considerations, such as future manufacturability.

In this opinion piece, Neil Ward explores how advances in sequencing could help to provide new insights for rare disease patients.

Insight into the history of human–pathogen interactions, how different societies responded to disease and the origin of pathogens supports our understanding of human health and evolution. We explore what we're still learning about ancient pathogens and diseases.

A microbiome analysis study highlights that pandemic-related lifestyle changes may be responsible for alterations seen in the microbial profile of the small intestine before versus during the COVID-19 pandemic.

Our food system is at a pivotal moment; there is enormous potential for innovation to unlock more healthy, accessible and sustainable diets for all, but we are simultaneously facing huge global challenges.